Premium
Proteomics and metabolomics — Current and future perspectives in clinical andrology
Author(s) -
Panner Selvam Manesh Kumar,
Finelli Renata,
Agarwal Ashok,
Henkel Ralf
Publication year - 2021
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.13711
Subject(s) - metabolomics , proteomics , male infertility , infertility , semen , proteome , bioinformatics , semen analysis , biology , medicine , computational biology , andrology , genetics , pregnancy , gene
Proteomics and metabolomics are emerging as promising tools to investigate the molecular mechanisms associated with male infertility. Proteins and metabolites play a pivotal role in regulating the molecular pathways associated with physiological functions of spermatozoa. Semen analysis, physical examination and laboratory work up cannot identify the etiology of infertility in 30%‐40% of cases, which are classified as idiopathic. Therefore, the application of proteomics and metabolomics in the field of andrology will aid to overcome the limitations of the standard semen analysis. Understanding the molecular pathways associated with male infertility will help in planning ad hoc treatments, contributing to the clinical management of infertile patients. In this review, proteomics and metabolomics studies on spermatozoa and seminal plasma are discussed with a focus on molecular biomarkers associated with male infertility‐related conditions.